Frazier Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.69K Hold
74
﹤0.01% 472
2025
Q4
$6.66K Hold
74
﹤0.01% 428
2025
Q3
$7.29K Hold
74
﹤0.01% 401
2025
Q2
$6.75K Hold
74
﹤0.01% 415
2025
Q1
$8.38K Hold
74
0.01% 367
2024
Q4
$7.8K Hold
74
0.01% 384
2024
Q3
$7.99K Sell
74
-7
-9% -$764 0.01% 419
2024
Q2
$8.79K Hold
81
0.01% 472
2024
Q1
$10.7K Sell
81
-40
-33% -$5K 0.01% 398
2023
Q4
$14.7K Buy
+121
New +$13.5K 0.01% 278

Other funds holding ZBH

Frazier Financial Advisors's ZBH Position: Q1 2026 in Review

Frazier Financial Advisors held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 74 shares worth $6.69K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

Frazier Financial Advisors first reported a position in ZBH in Q4 2023 and has held it in 10 quarters since. The position peaked at $14.7K in Q4 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Frazier Financial Advisors held 74 shares of Zimmer Biomet worth $6.69K as of Q1 2026.
  • Frazier Financial Advisors left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q1 2026, its #472 holding.
  • Frazier Financial Advisors first reported a position in Zimmer Biomet in Q4 2023 and has held it in 10 quarters since.
  • Frazier Financial Advisors's Zimmer Biomet position peaked at $14.7K in Q4 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.